导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.78% | 686/1050 |
| 近一周 | 0.98% | 178/1104 |
| 近一月 | 0.48% | 104/1103 |
| 近一季 | -4.58% | 453/1092 |
| 近半年 | -10.87% | 800/1070 |
| 近一年 | -9.97% | 745/1018 |
| 近两年 | 81.65% | 300/926 |
| 近三年 | 49.20% | 272/834 |
| 成立以来 | 156.13% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.15% 660/1070 |
2.78% 649/1101 |
- - |
- - |
| 2025 | 31.95% 441/1065 |
12.37% 92/1014 |
3.47% 398/1038 |
27.34% 404/1050 |
-10.88% 909/1065 |
| 2024 | 10.72% 269/1011 |
-10.66% 786/960 |
-1.58% 411/983 |
12.25% 441/991 |
12.17% 47/1011 |
| 2023 | 37.53% 1/952 |
34.41% 5/880 |
6.24% 30/895 |
-8.68% 536/915 |
5.46% 17/952 |
| 2022 | -24.79% 487/867 |
-19.76% 505/773 |
-5.08% 760/806 |
-11.38% 334/845 |
11.43% 58/867 |
| 2021 | 40.72% 35/740 |
-5.38% 354/580 |
20.85% 154/659 |
6.20% 105/704 |
15.88% 18/740 |
| 2020 | 61.36% 188/554 |
-4.49% 274/419 |
31.97% 99/466 |
7.69% 308/517 |
18.87% 136/554 |
| 2019 | 40.45% 216/410 |
28.66% 446/1146 |
-2.37% 541/1228 |
4.21% 219/390 |
7.30% 267/410 |
| 2018 | -28.70% 199/349 |
- - |
2.11% 43/990 |
-12.39% 886/1000 |
-17.17% 957/1080 |
| 2017 | 6.15% 152/285 |
- - |
- - |
- - |
- - |
| 2016 | -22.80% 130/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 金鹰科技创新股票A VS. 东吴新产业精选股票A(580008) |